Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,268 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Australian Trial in Acute Hepatitis C

NCT00192569

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • 407 Doctors Darlinghurst, New South Wales, Australia
  • Holdsworth House GP Practice Darlinghurst, New South Wales, Australia
  • Kirketon Road Centre Darlinghurst, New South Wales, Australia
View all 18 locations
View Trial Details
Completed

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

NCT00036608

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Investigator Birmingham, Alabama, United States
  • Local Investigator Tucson, Arizona, United States
  • Local Investigator La Jolla, California, United States
  • Local Investigator Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

NCT00035633

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Investigator Birmingham, Alabama, United States
  • Local Investigator Tucson, Arizona, United States
  • Local Investigator La Jolla, California, United States
  • Local Investigator Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

NCT00051038

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Local Institution New Haven, Connecticut, United States
  • Local Institution Altamonte Springs, Florida, United States
  • Local Institution Lousiville, Kentucky, United States
  • Local Institution Charlotte, North Carolina, United States
View Trial Details
Completed

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy

NCT00067782

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Local Institution Phoenix, Arizona, United States
  • Local Institution West Hollywood, California, United States
  • Local Institution Washington D.C., District of Columbia, United States
  • Local Institution Altamonte Springs, Florida, United States
View all 19 locations
View Trial Details

Related conditions